Dr. Kuo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1601B Trinity St Stop Z1500
Austin, TX 78712Phone+1 512-495-5557Fax+1 512-495-5610
Summary
- Dr. John Kuo is a board-certified neurosurgeon-scientist who serves as University Vice President and Chair Professor at China Medical University in Taichung, Taiwan. He is a senior leader at Taiwan’s top ranked private university composed of 9 colleges, over 7000 students and trainees, with the 2nd largest integrated academic health system of 6 major hospitals and clinics of 5200+ beds across Taiwan. He was selected as a prestigious Yu Shan Scholar by Taiwan’s Ministry of Education.
He is also a Professor and served as the past-Inaugural Chair of the Dept. of Neurosurgery at Dell Medical School of The University of Texas at Austin. He received his MD from Harvard Medical School and PhD degree from MIT, then trained at University of Southern California and University of Toronto. He specializes in surgery for brain tumors, pituitary tumors, stereotactic radiosurgery for brain tumors, brain metastases and trigeminal neuralgia, and managing complex brain tumor patients. Dr. Kuo leads a research group that studies cancer stem cell biology, developing new cancer diagnostics and therapeutics, and conduct clinical trials of new cancer agents. At UT Austin, he recruited and led a new department of neurosurgery dedicated to advancing the clinical care & full spectrum research and educational frontiers for children and adults with brain and spine diseases via new surgical techniques and devices, novel therapies, and engineering new technologies in multidisciplinary teams focused on advancing brain-computer interface, neurorehabilitation, brain and spine trauma, cerebrovascular/stroke and brain tumor translational research groups. He was also Surgical director of the UT Mulva Clinic for the Neurosciences, an interdisciplinary enterprise of Neurosurgery, Neurology, Psychiatry, and Basic Neurosciences focused on improving outcomes for patients with neurological disorders.
Education & Training
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Neurological Surgery, 1998 - 2005
- University of Southern California/LACUSC Medical CenterFellowship, Stereotactic Radiosurgery, 2002 - 2003
- Harvard Medical SchoolClass of 1998
Certifications & Licensure
- TX State Medical License 2018 - 2026
- CA State Medical License 1999 - 2025
- WI State Medical License 2005 - 2019
- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- Top Doctors Austin Monthly, 2020-2022
- America's Top Doctors Castle Connolly, 2012-2022
- Fellow (FAANS) American Association of Neurological Surgeons
- Join now to see all
Clinical Trials
- Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 71 citationsMicrofluidics-based devices: New tools for studying cancer and cancer stem cell migration.Yu Huang, Basheal Agrawal, Dandan Sun, John S. Kuo, Justin C. Williams
Biomicrofluidics. 2011-03-30 - 81 citationsTranscriptomic comparison of human and mouse brain microvesselsHannah W. Song, Koji L. Foreman, Benjamin D. Gastfriend, John S. Kuo, Sean P. Palecek
Scientific Reports. 2020-07-23 - 36 citationsNavigating the Collagen Jungle: The Biomedical Potential of Fiber Organization in Cancer.Jonathan N. Ouellette, Cole R. Drifka, Kelli B. Pointer, Yuming Liu, Tyler J Lieberthal
Bioengineering. 2021-01-21
Journal Articles
- Potential CAR T Cell Immunotherapy Against Diffuse Midline GliomasJohn Kuo, MD, Neurosurgery
Press Mentions
- UW Study Uses 'Bio-Panning' to Find Human Antibodies for Brain Cancer Stem CellsNovember 27th, 2017
- Coming Soon: Glow-in-the-Dark Cancer SurgeryJanuary 20th, 2017
- Tumor-Targeting Agent Attaches to Cancer Cells: Study - US NewsJune 11th, 2014
- Join now to see all
Committees
- Executive Committee, AANS/CNS Joint Section on Tumors 2013 - Present
- Member, AANS Digital Content Committee 2020 - 2022
- Co-Chair, UW Madison Biological Sciences Executive Committee 2017 - 2018
- Chair, AANS Memberships Committee 2015 - 2018
Professional Memberships
- Member
- Member
- Fellow
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: